Collaborative Research Development Grant

2024 Grant Recipients

• Alberto Ciccia, PhD, Columbia University
  Defining the impact of DNA repair variants on immune-based therapy of ovarian cancer at scale
• Selvendiran Karuppaiyah, PhD, The Ohio State University
  Identification of early molecular events and a novel biomarker for high grade serous ovarian cancer
• Bethany Hannafon, PhD, University of Oklahoma Health Sciences Center
  Development of a novel DCLK1-targeted CAR-T to prevent ovarian cancer metastatic recurrence

2023 Grant Recipients

• Kristopher Sarosiek, PhD,
  Targeting Apoptotic Vulnerabilities in Ovarian Cancer
• Simon Gayther, PhD, Cedars-Sinai Medical Center
  iPSC Modeling of Ovarian Cancers in BRCA1 and 2 Mutation Carriers

2022 Grant Recipients

• Jen-Tsan Chi, MD, PhD, Duke University
  The Role of Ferroptosis in the Metastatic Ovarian Cancer
• Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute
  Role of Macrophage-secreted BIGH3 in Tumor Immunity
• Benjamin Bitler, PhD, University of Colorado - Denver
  A Machine Learning Approach to Chemotherapy-induced Remodeling of the Tumor

2021 Grant Recipients

• Martin Cannon, PhD, University of Arkansas for Medical Sciences
  Understanding and Targeting Myeloid Populations in Ovarian Cancer
• Ivan Ahel, PhD, University of Oxford
  Exploiting PARP-Modulating Enzymes in Ovarian Cancer Therapy

2020 Grant Recipients

• Andrew K. Godwin, PhD, University of Kansas Medical Center Research Institute
  Tumor-Derived Extracellular Vesicle in Ovarian Cancer
• Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center
  Profiling Co-Evolution of Ovarian Cancer and its Immune Microenvironment
• Ugo Cavallaro, PhD, Fondazione Istituto Europeo di Oncologia e Centro Cardiologico Fondazione Monzino
  Interplay Between Ovarian Cancer Stem Cells and the Tumor Microenvironment
• Sandra Orsulic, PhD, UCLA School of Medicine
  Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma

2019 Grant Recipients

• Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute
  Targeting Tumor Desmoplasia to Enhance Immunotherapy
• Rugang Zhang, PhD, The Wistar Institute
  Developing Epigenetic Therapies for Ovarian Cancer

2018 Grant Recipients

• Gordon Mills, MD, PhD, MD Anderson Cancer Center
  Rational Combination Therapy in Ovarian Cancer
• David Sabatini, MD, PhD, Whitehead Institute for Biomedical Research
  A Personalized Approach to Identify and Target Ovarian Cancer Liabilities

2017 Grant Recipients

• Tyler Curiel, MD, University of Texas Health Science Center at San Antonio
  Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
• Ronen Marmorstein, PhD, University of Pennsylvania
  Chromatin Regulatory Mechanisms in Ovarian Cancer
• Kenneth Nephew, PhD, Indiana University
  Epigenetic Vulnerabilities of Ovarian Cancer Stem Cells
• Ie-Ming Shih, MD, PhD, Johns Hopkins University School of Medicine
  Development of Targeted Therapies for Recurrent Ovarian Cancer

2016 Grant Recipients

• Beth Y. Karlan, MD, Cedars-Sinai Medical Center
  Co-Evolution of Epithelial Ovarian Cancer and Tumor Stroma
• David Spriggs, MD, Memorial Sloan Kettering Cancer Center
  Novel Approaches to Immunotherapy

2015 Grant Recipients

• Anna Lokshin, PhD, University of Pittsburgh
  Microenvironmental Control of Premalignant Lesions in Ovarian Cancer
• Alexander Nikitin, MD, PhD, Cornell University
  Cancer-prone Stem Cell Niches in Ovarian and Tubal Epithelia
• Michael Yaffe, MD, PhD, Massachusetts Institute of Technology
  Using Functional Genetics and Nanomedicine for Ovarian Cancer Treatments

2014 Grant Recipients

• Tyler Curiel, MD, University of Texas Health Science Center at San Antonio
  Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
• Ronen Marmorstein, PhD, University of Pennsylvania
  Chromatin Regulatory Mechanisms in Ovarian Cancer
• Ursula Matulonis, MD, Dana Farber Cancer Institute
  Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy

2013 Grant Recipients

• Simon Gayther, PhD, University of Southern California
  Functional Analysis of Genetic Susceptibility Loci to Identify Biomarkers and Candidate Genes Associated with Ovarian Cancer Initiation, Progression and Outcome
• Anil K. Sood, MD, MD Anderson Cancer Center
  Power of Platelets in Ovarian Cancer
• Elizabeth Swisher, MD, University of Washington
  The FA-BRCA Pathway and Response to Platinum and PARP Inhibitors in Ovarian, Tubal and Peritoneal Carcinomas

2012 Grant Recipients

• George Coukos, M.D., Ph.D., University of Pennsylvania
  Engineering Immune Cells to Better Recognize and Kill Ovarian Cancer
• Ernst Lengyel, MD, PhD, University of Chicago
  Reprogramming of Ovarian Cancer Microenvironments by miRNAs
• Martin Matthew Matzuk, MD, PhD, Baylor College of Medicine
  Diagnostic Strategies for Detection of Ovarian Cancer

2011 Grant Recipients

• Kenneth Nephew, PhD, Indiana University
  A New Approach to Treating Recurrent Ovarian Cancer and Newly Diagnosed Disease
• Santo Nicosia, MD, University South Florida
  Ovarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
• Weiping Zou, MD, PhD, University of Michigan - Ann Arbor
  Understanding how Ovarian Cancer Stem Cells Play a Role in Disease Progression and Drug Resistance

2009 Grant Recipients

• Andrew Berchuck, MD, Duke University Medical Center
  International Ovarian Cancer Association Consortium: Finding Genetic Markers of Ovarian Cancer Using Polymorphisms
• Andrew K. Godwin, PhD, Fox Chase Cancer Center
  Understanding the Microenvironment Where Ovarian Cancer Grows as a Target for Treatment
• Anil K. Sood, MD, MD Anderson Cancer Center
  Novel Treatments for Ovarian Cancer Using siRNAs

2008 Grant Recipients

• Gary Leiserowitz, MD, University of California - Davis
  The Carbohydrate Components of Cellular Molecules: A New Way to Diagnose Ovarian Cancer?
• George Coukos, M.D., Ph.D., University of Pennsylvania
  Engineering T Cells to Augment Natural Immunity to Ovarian Cancer
• Robert C. Bast Jr., MD, MD Anderson Cancer Center
  Autophagy and Ovarian Cancer

2007 Grant Recipients

• Kunle Odunsi, MD, PhD, Roswell Park Cancer Institute
  Enhancing Immunity to Ovarian Cancer Tumors
• Martin Matthew Matzuk, MD, PhD, Baylor College of Medicine
  MicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
• Jonathan S. Berek, MD, MMS, Stanford University
  Leading the Effort to Develop Vaccines and Immunotherapy for Ovarian Cancer

2006 Grant Recipients

• Bo Rueda, PhD, Massachusetts General Hospital
  Understanding the Key Molecular Pathways that Drive Ovarian Cancer
• Peter Laird, PhD, University of Southern California/Keck Medical School
  Molecular Changes to DNA that Contribute to Ovarian Cancer
• Ronny I. Drapkin, MD, PhD, Dana Farber Cancer Institute
  Ovarian Cancer Biomarkers: Identification, Validation and Assessment of Biological Function

2005 Grant Recipients

• Anil K. Sood, MD, MD Anderson Cancer Center
  Novel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
• Andrew K. Godwin, PhD, Fox Chase Cancer Center
  Therapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer
• Andrew Berchuck, MD, Duke University Medical Center
  International Ovarian Cancer Association Consortium

2004 Grant Recipients

• Carol Aghajanian, MD, PhD, Memorial Sloan Kettering Cancer Center
  Novel Approaches to Ovarian Cancer Treatment